Brief: Bavarian Nordic’S Chikungunya Vaccine Receives Recommendation From U.S. CDC’S Advisory Committee On Immunization Practices
16/04/2025 21:12
April 16 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC’S CHIKUNGUNYA VACCINE RECEIVES RECOMMENDATION FROM U.S. CDC’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) Source text: ID:nGNX7yGQDh Further company coverage: BAVA.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline